ASX - Delayed Quote • AUD
Medical Developments International Limited (MVP.AX)
At close: April 26 at 4:10 PM GMT+10
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Brent MacGregor | Chief Executive Officer | 758.49k | -- | 1964 |
| Ms. Anita James | Chief Financial Officer | 430.31k | -- | -- |
| Matthew Cramer | Chief of Operations & Supply Chain | -- | -- | -- |
| Ms. Tara Eaton | General Counsel & Company Secretary | -- | -- | -- |
| Dr. Scott Courtney | Chief Scientific Officer | -- | -- | -- |
| Wai Ng Chi | Head of Regulatory Affairs | -- | -- | -- |
| Wayne Pearce | Head of Production | -- | -- | -- |
| Mr. Stefaan Schatteman | Head of Europe | -- | -- | -- |
Medical Developments International Limited
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices. The company also provides asthma and COPD products, such as space chambers and silicone face masks. The company was founded in 1971 and is headquartered in Scoresby, Australia.
Corporate Governance
Medical Developments International Limited’s ISS Governance QualityScore as of April 1, 2024 is 4. The pillar scores are Audit: 4; Board: 3; Shareholder Rights: 1; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Mar 05, 2020Ex-Dividend Date
Upcoming Events
Feb 29, 2024
Medical Developments International Limited Earnings Call
Related Tickers
EPN.AX Epsilon Healthcare Limited
0.0240
0.00%
VLS.AX Vita Life Sciences Limited
2.2400
+4.19%
ECS.AX ECS Botanics Holdings Ltd
0.0220
0.00%
IVX.AX Invion Limited
0.0060
0.00%
EOF.AX Ecofibre Limited
0.0610
0.00%
LV1.AX Live Verdure Ltd
0.7450
-1.97%
LGP.AX Little Green Pharma Ltd
0.1250
-3.85%
PBP.AX Probiotec Limited
2.8300
-0.35%
PPLPHARMA.BO Piramal Pharma Limited
142.30
+0.21%
IDT.AX IDT Australia Limited
0.0950
-2.06%